Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Ferring Pharmaceuticals | INDUSTRY |
Not provided
Not provided
Not provided
Whether it is for oncology or personal reasons, fertility preservation allows participants to preserve their oocytes (eggs) at their current age and condition for a better chance of having a baby in the future.
In order to proceed with fertility preservation, participants will need to undergo in vitro fertilization (IVF), which is standard practice, and take stimulation medication to stimulate production of more follicles.
The combination of both Rekovelle and Menopur for fertility preservation may increase ovarian response to stimulation and increase the number of oocytes retrieved to give better chances of embryos once the oocytes will be fertilized.
The goal in this study is to understand the effect of oxydative stress on the quality of oocytes.
For the purpose of the study and to evaluate this connection, serum levels of oxidative stress and cf-DNA in your blood will be measured.
Oocyte quality will also be assessed with Magenta, a prediction tool utilizing artificial intelligence (AI). This method is non-invasive and has no risks on the oocytes.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Oncology preservation | Other |
| |
| Social (elective) preservation | Other |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Oxidative stress | Other | Oxidative stress occurs as soon as there is an imbalance between pro- / antioxidants, and molecules exhibiting antioxidant properties are at the forefront of fertility treatment and preservation. Oxidated stress will be measured by blood sample |
| Measure | Description | Time Frame |
|---|---|---|
| Evaluate the correlation between the oxidative stress and the quality of oocytes | Serum sample measure variations of oxidation-reduction potential (ORP) with MiOXSYS analyzer and by PCR | Change from baseline oxidative stress at the end of IVF controlled ovarian stimulaition |
| Measure | Description | Time Frame |
|---|---|---|
| Evaluation of oocyte quality by visualization | Oocyte quality will be measured by MAGENTA AI | At the end of IVF stimulation |
| Assessment of good quality oocytes | Measurement of serum estradiol levels |
Not provided
Inclusion Criteria:
- Women 18 to 37 years of age inclusively eligible for fertility preservation for either social or oncology reason
Exclusion Criteria:
Women undergoing fertility preservation for oncology or social purposes
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Olive Fertility Centre | Vancouver | British Columbia | V5Z 3X7 | Canada | ||
| Ottawa Fertility Centre |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D018384 | Oxidative Stress |
| ID | Term |
|---|---|
| D008660 | Metabolism |
| D013312 | Stress, Physiological |
| D010829 | Physiological Phenomena |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| cf-DNA | Other | cfDNA, extracted from blood plasma in samples collected will uncover the potential role of cfDNA as a stress signal released in response to oxidative stress |
|
| MAGENTA AI | Other | Non-invasive technique analyzing images of oocytes that can differentiate oocytes with a higher reproductive potential reflective of their quality |
|
| IVF stimulation cycle |
| Number of mature oocytes retrieved | Efficacy of the combination or Rekovelle and Menopur | IVF stimulation cycle |
| Ottawa |
| Ontario |
| K2C 3V4 |
| Canada |
| Clinique Ovo | Montreal | Quebec | H4P 2S4 | Canada |